CAL-101 100mg 100mg | Purity Not Available
Adooq Bioscience
CAL-101 is an isoform-selective inhibitor of PI3K that induces apoptosis of chronic lymphocytic leukemia (CLL) cells.
More Information Supplier PageCAL-101 is an isoform-selective inhibitor of PI3K that induces apoptosis of chronic lymphocytic leukemia (CLL) cells.
More Information Supplier PageCAL-101 is an isoform-selective inhibitor of PI3K that induces apoptosis of chronic lymphocytic leukemia (CLL) cells.
More Information Supplier PageCaffeic acid is an organic compound that is classified as hydroxycinnamic acid.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBTZ043 (BTZ038, BTZ044) inhibits decaprenylphosphoryl-??-d-ribose 2?-epimerase, which is an enzyme which produces the cell wall of the pathogenic bacterium Mycobacterium tuberculosis.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier PageBSI-201 is a potent inhibitor of PARP-1 and has been shown to cross the blood-brain barrier.
More Information Supplier Page